Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| KYNTRA BIO, INC.FGEN · Entity 7431 | SVP, CHINA OPERATIONS | March 06, 2025 | March 08, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
KYNTRA BIO, INC.
Report date March 06, 2025 · Filed March 08, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 294,903 |
Ending reported balance
After 2025-03-06 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2025-03-06 · Tax withholding · Disposed 7,008 · Balance 294,544 F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Row 2 · 2025-03-06 · Grant · Acquired 781 · Balance 295,325 F2: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025. Row 3 · 2025-03-06 · Tax withholding · Disposed 422 · Balance 294,903 F3: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units.
F2: Represents the number of shares released for PSU Milestone Grant vested on March 6, 2025.
F3: Represents the number of shares withheld by the issuer to cover the tax obligation realized upon the vesting of PSU Milestone grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2020 Filed Jun 10, 2020 23:48 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,038 | $33.61 | $102,107.18 |
DisclosureSEC source: 0001209191-20-035698 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 156,653 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. F2 · balance_after: Includes 678 shares acquired on May 15, 2020 through the Issuer's Employee Stock Purchase Plan. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,345 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · derivative · entry 13 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,719 Underlying: Common Stock · 7,345 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 6,215 | $26.08 | $162,087.20 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 10 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,013 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F9 · price: The shares were sold at prices ranging from $25.71 to $26.525. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 830 | $25.32 | $21,015.60 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 9 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,228 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F8 · price: The shares were sold at prices ranging from $24.71 to $25.70. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 300 | $23.93 | $7,179.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,058 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F7 · price: The shares were sold at prices ranging from $23.50 to $24.42. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 19, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 7,345 | $25.40 | $186,563.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,358 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 400 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · derivative · entry 12 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,064 Underlying: Common Stock · 400 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2018, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,500 | $25.68 | $38,520.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,013 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F6 · price: The shares were sold at prices ranging from $25.26 to $26.25. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 1,500 | $24.56 | $36,840.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,513 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $24.13 to $25.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 905 | $23.69 | $21,439.45 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,013 F3 · shares: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $23.10 to $24.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 18, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 400 | $25.40 | $10,160.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,918 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantStock Option (Right to Buy) · Derivative | 66,250 | $0.00 Strike: $26.41 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · derivative · entry 11 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,250 Underlying: Common Stock · 66,250 shares Expires 2030-03-17 F10 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vests on March 1, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 17, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | GrantCommon Stock | 40,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 162,518 F2 · shares: Represents the grant of restricted stock units. Twenty-five percent of the restricted stock units vest on March 6, 2021, and the remainder vests in equal amounts quarterly thereafter for the following three years. Read SEC document |
| March 06, 2020 Filed Mar 19, 2020 23:55 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 10,126 | $39.71 | $402,103.46 |
DisclosureSEC source: 0001209191-20-020354 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,518 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:36 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · derivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,464 Underlying: Common Stock · 5,625 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:36 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 600 | $46.28 | $27,768.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,644 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $46.22 to $46.435. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:36 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,025 | $45.94 | $230,848.50 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,244 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $45.22 to $46.21. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 12, 2020 Filed Feb 13, 2020 22:36 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $25.40 | $142,875.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:36 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · derivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,089 Underlying: Common Stock · 5,625 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:36 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $44.48 | $250,200.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,644 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $43.77 to $44.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| February 11, 2020 Filed Feb 13, 2020 22:36 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $25.40 | $142,875.00 |
DisclosureSEC source: 0001209191-20-009365 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 02:12 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-002650 · doc4.xml · derivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,714 Underlying: Common Stock · 5,625 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 02:12 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $42.76 | $240,525.00 |
DisclosureSEC source: 0001209191-20-002650 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,644 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $42.49 to $43.07. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 07, 2020 Filed Jan 9, 2020 02:12 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $25.40 | $142,875.00 |
DisclosureSEC source: 0001209191-20-002650 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 02:12 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-20-002650 · doc4.xml · derivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,339 Underlying: Common Stock · 5,625 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 02:12 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $42.98 | $241,762.50 |
DisclosureSEC source: 0001209191-20-002650 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,644 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $42.555 to $43.36. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| January 06, 2020 Filed Jan 9, 2020 02:12 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $25.40 | $142,875.00 |
DisclosureSEC source: 0001209191-20-002650 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · derivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,964 Underlying: Common Stock · 5,625 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 289 | $47.47 | $13,718.83 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · nonDerivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,644 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F5 · price: The shares were sold at prices ranging from $47.46 to $47.49. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,336 | $46.95 | $250,525.20 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,933 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $46.40 to $47.365. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 17, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $25.40 | $142,875.00 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,120 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · derivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,589 Underlying: Common Stock · 2,120 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,775 | $47.37 | $131,451.75 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,644 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $47.23 to $47.52. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,850 | $46.80 | $133,380.00 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 135,419 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $46.20 to $47.19. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 16, 2019 Filed Dec 19, 2019 01:33 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 2,120 | $25.40 | $53,848.00 |
DisclosureSEC source: 0001209191-19-061218 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2019 Filed Dec 10, 2019 01:10 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Tax withholdingCommon Stock | 3,479 | $47.39 | $164,869.81 |
DisclosureSEC source: 0001209191-19-059776 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 136,149 F1 · shares: Represents shares withheld by the issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,291 | $0.00 Strike: $25.40 | $0.00 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · derivative · entry 9 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,709 Underlying: Common Stock · 2,291 shares Expires 2027-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,334 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · derivative · entry 8 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 3,334 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,025 | $35.18 | $71,239.50 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · nonDerivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,628 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $34.99 to $35.45. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 3,600 | $34.50 | $124,200.00 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 141,653 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $33.985 to $34.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 2,291 | $25.40 | $58,191.40 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 14, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 3,334 | $19.39 | $64,646.26 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 142,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · derivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,334 Underlying: Common Stock · 5,625 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $34.54 | $194,287.50 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · nonDerivative · entry 2 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,628 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F2 · price: The shares were sold at prices ranging from $34.20 to $34.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 13, 2019 Filed Nov 15, 2019 23:07 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $19.39 | $109,068.75 |
DisclosureSEC source: 0001209191-19-056806 · doc4.xml · nonDerivative · entry 1 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 09, 2019 Filed Oct 10, 2019 23:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-052982 · doc4.xml · derivative · entry 7 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,959 Underlying: Common Stock · 5,625 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| October 09, 2019 Filed Oct 10, 2019 23:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 5,625 | $36.58 | $205,762.50 |
DisclosureSEC source: 0001209191-19-052982 · doc4.xml · nonDerivative · entry 5 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,628 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F4 · price: The shares were sold at prices ranging from $36.30 to $36.995. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 09, 2019 Filed Oct 10, 2019 23:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionCommon Stock | 5,625 | $19.39 | $109,068.75 |
DisclosureSEC source: 0001209191-19-052982 · doc4.xml · nonDerivative · entry 4 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,253 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 08, 2019 Filed Oct 10, 2019 23:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,625 | $0.00 Strike: $19.39 | $0.00 |
DisclosureSEC source: 0001209191-19-052982 · doc4.xml · derivative · entry 6 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,584 Underlying: Common Stock · 5,625 shares Expires 2026-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Twenty-five percent of the shares subject to the option vested on March 1, 2017, and the remainder vest in equal amounts quarterly thereafter for the following three years. Read SEC document |
| October 08, 2019 Filed Oct 10, 2019 23:57 UTC | KYNTRA BIO, INC. FGEN · Entity 7431 | SaleCommon Stock | 2,400 | $37.10 | $89,040.00 |
DisclosureSEC source: 0001209191-19-052982 · doc4.xml · nonDerivative · entry 3 Chung Christine · CIK 0001775295 · SVP, China Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,628 F1 · kind: Shares sold pursuant to a 10b5-1 plan. F3 · price: The shares were sold at prices ranging from $37.00 to $37.24. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.